Pregnancy Cohort in Multiple Sclerosis (MS)

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Aug 17, 2021

Keywords

ClinConnect Summary

This clinical trial, called the Pregnancy Cohort in Multiple Sclerosis (MS), is studying how pregnancy affects women with multiple sclerosis (MS) and a related condition called clinically isolated syndrome (CIS). Researchers want to gather information about pregnancy outcomes for women with these conditions, as well as how their MS might change during and after pregnancy. This study is currently looking for female participants aged 18 and older who have been diagnosed with MS or CIS.

To join the trial, participants need to provide signed consent and not have any serious other health issues or conditions that would prevent them from having an MRI scan (a type of imaging test). If eligible, women in the study can expect to share details about their pregnancies and undergo some clinical assessments, including MRI scans, to help researchers learn more about the impact of pregnancy on MS. This information could be very valuable for understanding how to best support women with MS during this important time in their lives.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • age \> 18 years
• • signed informed consent
• • diagnosis of multiple sclerosis or clinically isolated syndrome
• Exclusion Criteria:
• • clinically relevant comorbidities
• • contraindications for MRI, e.g. pacemaker, metal implants, allergy against gadolinium
• • alcohol or drug abuse